Clinical Trial Update: Extended Treatment With Vancomycin for Clostridium Difficile Colitis [NA]

View source ↗

Summary

The clinical trial NCT00861887 evaluating extended vancomycin treatment for Clostridioides difficile infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Corewell Health East | Conditions: Clostridium Difficile Colitis | NA | Status: WITHDRAWN